Drug profile · INN
octocog alfa
ADVATE
octocog alfa (ADVATE) is a coagulation factor viii exogenous protein. Associated with Takeda.
EMA: approved Blood and blood forming organs (B02) B02BD02
Patents linked 0
Pipeline programs 9
News articles 0
Drug details — octocog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 9
- Data quality
- 0.89
Quick answer
octocog alfa (ADVATE) is a coagulation factor viii exogenous protein. Associated with Takeda.
Key facts
INN octocog alfa
Brand ADVATE
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD02
Originator Takeda
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is octocog alfa?
octocog alfa (ADVATE) is a coagulation factor viii exogenous protein. Associated with Takeda.
What is the brand name for octocog alfa?
ADVATE is a marketed brand name for octocog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.